Eli Lilly (LLY) earnings Q2 2026

Eli Lilly on Wednesday reported second-quarter earnings and revenue that blew past estimates and hiked its full-year sales outlook, as demand for its blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro surged again. The pharmaceutical giant now expects 2026 revenue…

Read More